• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. AFFERA; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. AFFERA; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH Back to Search Results
Model Number AFR-00001
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Heart Block (4444)
Date of Event 05/04/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product event summary: the afr-00001 affera¿ sphere-9¿ catheter with lot 0233235815 and data files were returned and analyzed.The log files were analyzed, and timestamps/errors were observed with catheter serial number (b)(6).During external visual inspection, the catheter was found to be intact, and no defects were observed.The cirris tester was used on the catheter for shorts and mapping tests, and the tests passed successfully.The catheter was functionally tested using test capital equipment.Radiofrequency (rf) and pulse field ablations were completed successfully with the catheter.A new map was started, and the catheter was able to map appropriately.In conclusion, the reported clinical issues cannot be assessed through data analysis.The catheter passed the returned product inspection per specification.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that an affera mapping system with a sphere 9 catheter was used during a ventricular tachycardia ablation, two ventricular tachycardia morphologies were induced with suspected origin from the inferior septum of the left ventricle, and premature ventricular contractions were described as a suspected trigger for ventricular tachycardia or ventricular fibrillation.A scar map was created during right ventricular lead pacing and left ventricular scar homogenization was performed on the inferior and septal walls, including lesion delivery at the inferior basal septum and at the left posterior fascicle based on mapped signals including purkinje potentials.Pulsed field ablation and radiofrequency ablation lesions were delivered, and complete type 3 heart block was later recognized after ablation performed under left ventricular pacing, with a concern that the posterior fascicle may have been the only remaining conduction pathway.The procedure was aborted while the patient was under general anesthesia after recognition of complete heart block, and another manufacturer's biventricular implantable cardioverter defibrillator was implanted.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFFERA
Common Device Name
PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH
Manufacturer (Section D)
MEDTRONIC, INC.
880 technology park drive
billerica MA 01821
Manufacturer (Section G)
MEDTRONIC, INC.
880 technology park drive
billerica MA 01821
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key25228811
Report Number3012520654-2026-00221
Device Sequence Number5105224
Product Code QZI
UDI-Device Identifier00763000973391
UDI-Public(01)00763000973391(17)270315(10)0233235815
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P240013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberAFR-00001
Device Catalogue NumberAFR-00001
Device Lot Number0233235815
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/04/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/04/2026
Initial Report FDA Received Date05/20/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/13/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient SexMale
-
-